Related references
Note: Only part of the references are listed.Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2) : a phase 3, double-blind, randomised, placebo-controlled trial
Eugenio Mercuri et al.
LANCET NEUROLOGY (2022)
In vitro fertilization with preimplantation genetic testing for monogenetic diseases versus unassisted conception with prenatal diagnosis for Huntington disease: a cost-effectiveness analysis
Alicia A. Christensen et al.
FERTILITY AND STERILITY (2022)
Estimated Travel Time and Spatial Access to Abortion Facilities in the US Before and After the Dobbs v Jackson Women's Health Decision
Benjamin Rader et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Cost-effectiveness analysis of gene-based therapies for patients with spinal muscular atrophy type I in Australia
Tianjiao Wang et al.
JOURNAL OF NEUROLOGY (2022)
Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments
Tamara Dangouloff et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
John W. Day et al.
LANCET NEUROLOGY (2021)
Spinal muscular atrophy: From approved therapies to future therapeutic targets for medicine
Helena Chaytow et al.
CELL REPORTS MEDICINE (2021)
Economic burden of spinal muscular atrophy in the United States: a contemporary assessment
Marcus Droege et al.
JOURNAL OF MEDICAL ECONOMICS (2020)
Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations
Joseph H. Lipton et al.
HUMAN REPRODUCTION (2020)
Quality of life of patients with spinal muscular atrophy: A systematic review
Erik Landfeldt et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2019)
The role of survival motor neuron protein (SMN) in protein homeostasis
Helena Chaytow et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain
Julio Lopez-Bastida et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy a literature review
Ingrid E. C. Verhaart et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Practice patterns, satisfaction, and demographics of reproductive endocrinologists: results of the 2014 Society for Reproductive Endocrinology and Infertility Workforce Survey
Kurt T. Barnhart et al.
FERTILITY AND STERILITY (2016)
Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases
Matthew E. R. Butchbach
FRONTIERS IN MOLECULAR BIOSCIENCES (2016)
Spinal Muscular Atrophies
Basil T. Darras
PEDIATRIC CLINICS OF NORTH AMERICA (2015)
Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of > 72 400 specimens
Elaine A. Sugarman et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
The cost-effectiveness of prenatal screening for spinal muscular atrophy
Sarah E. Little et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
Perspectives of couples with high risk of transmitting genetic disorders
Anna M. Musters et al.
FERTILITY AND STERILITY (2010)
PGD for all cystic fibrosis carrier couples: novel strategy for preventive medicine and cost analysis
I. Tur-Kaspa et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2010)
Preimplantation genetic diagnosis after 20 years
Alan H. Handyside
REPRODUCTIVE BIOMEDICINE ONLINE (2010)
Cost-effectiveness of dilation and evacuation versus the induction of labor for second-trimester pregnancy termination
AA Cowett et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Share Paper
